Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025

Table of content

Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information procurement
2.2 Data Analysis
Chapter 3 Pharmacokinetics Services Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Focused efforts to establish a standardized pharmacokinetic monitoring approach
3.1.1.2 Robust drug pipeline and ongoing clinical studies
3.1.1.3 Conferences that aimed at growing awareness about the role of pharmacokinetics
3.1.2 Market restraint analysis
3.1.2.1 Limitations associated with in vitro PKPD studies
3.2 Penetration & Growth Prospect Mapping For Drug Type, 2017
3.3 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Pharmacokinetics Services Market: Drug Type Estimates & Trend Analysis
4.1 Pharmacokinetics Services Market: Drug Type Movement Analysis
4.2 Small Molecule Pharmacokinetics Services
4.2.1 Small molecule pharmacokinetic services market, 2013 - 2025 (USD Million)
4.3 Large Molecule Pharmacokinetic Services
4.3.1 Large molecule pharmacokinetic services market, 2013 - 2025 (USD Million)
Chapter 5 Pharmacokinetics Services Market: Regional Estimates & Trend Analysis, by Drug Type
5.1 Pharmacokinetics Services Market Share By Region, 2016 & 2025
5.2 North America
5.2.1 North America pharmacokinetics services market, 2013 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe pharmacokinetics services market, 2013 - 2025 (USD Million)
5.3.2 Germany
5.3.2.1 Germany pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
5.3.3 U.K.
5.3.3.1 U.K. pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific pharmacokinetics services market, 2013 - 2025 (USD Million)
5.4.2 China
5.4.2.1 China pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
5.4.3 India
5.4.3.1 India pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
5.4.4 Japan
5.4.4.1 Japan pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America pharmacokinetics services market, 2013 - 2025 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
5.6 Middle East and Africa
5.6.1 MEA pharmacokinetics services market, 2013 - 2025 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Evotec AG
6.3.1.1 Company overview
6.3.1.2 Cyprotex Limited
6.3.1.2.1 Company overview
6.3.1.3 Financial performance
6.3.1.3.1财务业绩
6.3.1.4 Product benchmarking
6.3.1.5 Strategic initiatives
6.3.2 Certara, L.P.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Pacific BioLabs
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 GVK Biosciences Private Limited
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Shanghai Medicilon Inc.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Pharmaceutical Product Development, LLC
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Charles River Laboratories International, Inc.
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 PAREXEL International Corporation
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 Eurofins Scientific, Inc.
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Frontage Labs
6.3.10.1 Company overview
6.3.10.2 Concord
6.3.10.2.1 Company overview
6.3.10.3 Financial performance
6.3.10.4 Product benchmarking
6.3.10.5 Strategic initiatives
6.3.11 SGS SA
6.3.11.1 Company overview
6.3.11.2 Financial performance
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 LGC Limited
6.3.12.1 Company overview
6.3.12.2 Financial performance
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 Creative Bioarray
6.3.13.1 Company overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives

List of Tables

TABLE 1 Top new drugs in the pipeline for 2018
TABLE 2 North America pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 3 U.S. pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 4 Canada pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 5 Europe pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 6 Germany pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 7 U.K. pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 8 Asia Pacific pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 9 China pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 10 India pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 11 Japan pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 12 Latin America pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
表13巴西药物动力学服务市场,by drug type, 2013 - 2025 (USD Million)
TABLE 14 MEA pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)
TABLE 15 South Africa pharmacokinetics services market, by drug type, 2013 - 2025 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Various multidisciplinary drug development functions that interfaces pharmacokinetics
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping for Application, 2017
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Pharmacokinetics services market: Drug type outlook key takeaways
FIG. 17 Pharmacokinetics services market: Drug type market movement analysis
FIG. 18 Global small molecule pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 19 Global large molecule pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 20 Regional market place: Key takeaways
FIG. 21 Pharmacokinetics market by region: Regional movement analysis
FIG. 22 North America pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 23 U.S. pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 24 Canada pharmacokinetic services market, 2013 - 2025 (USD Million)
图25欧洲药代动力学服务市场,2013 - 2025 (USD Million)
FIG. 26 Germany pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 27 U.K. pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 28 Asia Pacific pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 29 Breakdown of Chinese CRO industry
FIG. 30 China pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 31 India pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 32 Japan pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 33 Latin America pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 34 Brazil pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 35 MEA pharmacokinetic services market, 2013 - 2025 (USD Million)
FIG. 36 South Africa pharmacokinetic services market, 2013 - 2025 (USD Million)
图37策略framework
FIG. 38 Participant categorization